MKI67 and Merkel cell skin cancer: We observed that pyrvinium-treated MCC tumors exhibited a modest decrease in ATOH1 expression, coupled with decreased levels of Ki67, thus demonstrating reduced proliferation in drug-treated tumors (Figure 7D).